Persistent inflammation is known to promote and exacerbate malignancy. Primary liver
cancer, mostly hepatocellular carcinoma (HCC), is a clear example of inflammation-related …

The advent of immunotherapy has significantly reshaped the landscape of cancer treatment,
greatly enhancing therapeutic outcomes for multiple types of cancer. However, only a small …

A connection between inflammation and cancer has been long suspected. Epidemiological
studies have established that many tumors occur in association with chronic infectious …

Dysregulation of pleiotropic growth factors, receptors and their downstream signaling
pathway components represent a central protumorigenic principle in human …

Hepatocellular carcinoma (HCC) is one of the commonest causes of death from cancer. A
plethora of metabolomic investigations of HCC have yielded molecules in biofluids that are …

Hepatocellular carcinoma (HCC) is a common human cancer with high mortality, and
currently, there is no effective chemoprevention or systematic treatment. Recent evidence …

Background Despite well-studied tumor hypoxia in laboratory, little is known about the
association with other pathophysiological events in the clinical view. We investigated the …

Epidemiological studies have established that many tumours occur in association with
persistent inflammation. One clear example of inflammation-related cancer is hepatocellular …

Lemnalol (8-isopropyl-5-methyl-4-methylene-decahydro-1, 5-cyclo-naphthalen-3-ol) is a
natural compound isolated from the marine soft coral Lemnalia cervicorni. In the present …

Malignant gliomas (MG) are highly infiltrative tumors that consistently recur despite
aggressive treatment. Brain fatty acid-binding protein (FABP7), which binds …